Trend-Following Backtester · Guide · backtest 한국어

equity · US

Lexicon Pharmaceuticals, Inc. backtest

10 trend-following strategies were compared on the full daily history of Lexicon Pharmaceuticals, Inc.. 9 beat buy-and-hold CAGR; ADX / DI 방향성 ranks first by Sharpe, matching the main backtester. The return/drawdown alternative is ADX / DI 방향성 (CAGR 3.0%, MDD -20.9%).

Data 2000-04-07 ~ 2026-07-31daily bars 6,617 (26.3 years)Costs 0.5%Venue XNASMonthly snapshot 2026-07-31

Results by strategy

9 of 10 beat buy and hold (CAGR -14.3%, drawdown -99.9%).

Sharpe leader (same as main): ADX / DI 방향성 — CAGR 3.0%, MDD -20.9%, Sharpe 0.21, 1% exposure.

Return/drawdown alternative: ADX / DI 방향성 — CAGR is 17.3%p higher than buy and hold, while drawdown improves by 79.0%p (CAGR 3.0%, MDD -20.9%, exposure 1%).

The alternative must retain 75% of buy-and-hold CAGR, improve drawdown by at least 20% and 5 percentage points, and stay below 95% exposure; the ranking weights return retention 60% and drawdown improvement 40%.

Strategy · parametersCAGRMDDSharpeCalmarTotalTradesExposure
ADX / DI 방향성
period=18, threshold=54
3.0%-20.9%0.210.152.2x21%
Supertrend
period=15, mult=4.1
-6.3%-99.1%0.19-0.060.2x9946%
Donchian 채널 돌파
entryN=30, exitN=51
-10.4%-99.2%0.13-0.110.1x7754%
Keltner 채널 돌파
emaPeriod=22, atrPeriod=11, mult=3.9
1.0%-58.0%0.130.021.3x163%
MACD
fast=12, slow=21, signal=11
-10.5%-99.6%0.11-0.110.1x51649%
SMA 크로스오버
fast=30, slow=116
-6.6%-96.3%0.10-0.070.2x7941%
Parabolic SAR
step=0.015, maxStep=0.24
-11.4%-99.2%0.08-0.110.0x43645%
볼린저 밴드 돌파
n=53, k=2
-6.3%-94.7%0.08-0.070.2x9922%
EMA 크로스오버
fast=37, slow=159
-7.8%-96.1%0.04-0.080.1x5136%
ROC 모멘텀
n=45, threshold=0
-15.6%-99.8%-0.03-0.160.0x49145%
Buy and hold-14.3%-99.9%0.25-0.140.0x1100%
0.01 0.1 1x 2001 2005 2009 2013 2017 2021 2025 ADX / DI 방향성Buy and hold
ADX / DI 방향성: Solid strategy line versus dashed buy-and-hold line. Log scale.
0% -25% -50% -75% -100% 2001 2005 2009 2013 2017 2021 2025 Buy and holdADX / DI 방향성
ADX / DI 방향성 maximum drawdown -20.9% (2021-02-02 → 2021-02-26), prior peak not yet recovered.

Rules of the top strategy

Looks at both the direction and the strength of the trend; holds only in a strong uptrend.

Method and caveats

Past performance does not guarantee future returns. Parameters were selected on the same full-history sample using sharpe over 40 trials per strategy, so results contain in-sample bias. 0.5% trading costs are included; taxes, slippage and rejected orders are not.
Re-run the same setupAll asset reports

Read next